Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $392.19M.
ENTERPRISE VALUE (EV)
$392.19M
Assembly Biosciences, Inc.
Market Cap
$450.64M
Enterprise Value (EV)
$392.19M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $450.64M | $392.19M |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | $448.75M |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | $517.54M |
| NRC Health (NRC)vs › | $468.31M | $555.01M |
| Cerus Corporation (CERS)vs › | $471.57M | $530.39M |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | $261.85M |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | $470.40M |
| Arvinas, Inc. (ARVN)vs › | $481.33M | $395.23M |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | $248.13M |
| Carlsmed, Inc. (CARL)vs › | $415.93M | $391.60M |
Market Cap
$450.64M
Total Debt
$0.00
Cash
$58.45M
Enterprise Value
$392.19M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
